NeonMind Stock Begins Trading

NeonMind Biosciences Inc. (CSE: NEON) common shares have begun trading on the Canadian Securities Exchange under the ticker symbol “NEON”.  NeonMind is a psychedelic drug development company and the company recently completed its oversubscribed Initial Public Offering on December 30, 2020, for gross proceeds of $4.6 million.

“Our public listing is a significant milestone for us as we execute on our plan to grow our intellectual property portfolio and product development pipeline,” says NeonMind founder and CEO, Penny White, “We are extremely grateful to the investment community for their participation in our successful public offering and we look forward to strategically increasing shareholder value as we advance our business in the psychedelic sector.”

The company said in a statement that its mission is to help people change their lives by changing their minds, through treatment with psychedelics. Its initial focus will be on obesity. NeonMind said it is exploring the use of psilocybin (a complex organic compound found in psychedelic mushrooms) as a potential treatment for weight loss through a preclinical trial. It has hired the University of British Columbia, which has been granted authorization by Health Canada to use Psilocybin in NeonMind’s Preclinical Trial, to test the potential use of Psilocybin to improve eating habits and cause weight loss. The Preclinical Trial started in November 2020 and NeonMind expects to complete an application for a Phase 2 Human Trial in the spring of 2021.

NeonMind has filed 5 US provisional patent applications claiming methods of aiding in weight loss, treating a compulsive eating disorder, treating obesity or a complication of obesity, and/or altering the diet of an individual by administering psilocybin and/or other psychedelic compounds or their analogs or by administering psilocybin or its analog in conjunction with therapy or other treatments.

NeonMind is also pursuing commercialization of its catalog of proprietary medicinal mushroom product formulas. It recently launched a collection of four mushroom-infused coffees which are infused with medicinal mushrooms Lion’s Mane, Turkey Tail, Reishi, and Cordyceps.

2 comments

  • Avatar
    Mark Kirby

    January 4, 2021 at 6:16 pm

    Hello Staff,
    Where is NeonMind’s trading platform? I looked on Ameritrade where my other OTC and CSE stocks are traded. I also use Stash, which doesn’t have it either. So where can I buy CSE: NEON?

    I appreciate your site so much.

    Best,
    Kirby

    Reply

    • Debra Borchardt
      Debra Borchardt

      January 5, 2021 at 8:45 am

      Thank Mark for the kind words. Sometimes there is a lag on new stocks appearing on trading websites, we see this often on these little names. It appears to be on the CSE website as of this morning so that should make it available to the trading websites.

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 hours

Marijuana Money: January 15, 2021

@GreenMarketRpt – 1 day

⁦$CRLNF ⁦@crescolabs⁩ Buys $BMWLF Bluma Wellness In $213 Million Deal ⁦@BCobblaw⁩ ⁦@OnePlantUS⁩ #acquisition…

@GreenMarketRpt – 1 day

⁦@aphriainc⁩ $APHA Revenue Increases Along With Net Losses $TLRY

Back to Top

You have Successfully Subscribed!